These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20831497)

  • 1. Rectum motion and morbidity prediction: Improving correlation between late morbidity and DVH parameters through use of rectum planning organ at risk volumes.
    Thor M; Væth M; Karlsdottir A; Muren LP
    Acta Oncol; 2010 Oct; 49(7):1061-8. PubMed ID: 20831497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical simulations to estimate motion-inclusive dose-volume histograms for prediction of rectal morbidity following radiotherapy.
    Thor M; Apte A; Deasy JO; Muren LP
    Acta Oncol; 2013 Apr; 52(3):666-75. PubMed ID: 23205746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
    Guckenberger M; Meyer J; Baier K; Vordermark D; Flentje M
    Radiat Oncol; 2006 Sep; 1():34. PubMed ID: 16956403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
    Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the new ICRU 62 'Planning Organ at Risk Volume' concept for the rectum.
    Muren LP; Karlsdottir A; Kvinnsland Y; Wentzel-Larsen T; Dahl O
    Radiother Oncol; 2005 Jun; 75(3):293-302. PubMed ID: 15878630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on planning organ at risk volume for the rectum using cone beam computed tomography in the treatment of prostate cancer.
    Prabhakar R; Oates R; Jones D; Kron T; Cramb J; Foroudi F; Geso M; Gill S
    Med Dosim; 2014; 39(1):38-43. PubMed ID: 24412028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.
    Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
    Jiang R; Barnett RB; Chow JC; Chen JZ
    Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.
    O'Donnell HE; Finnegan K; Eliades H; Oliveros S; Plowman PN
    Br J Radiol; 2008 Apr; 81(964):327-32. PubMed ID: 18344276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of dose and volume on rectal tolerance.
    Gambacorta MA; Manfrida S; D'Agostino G; Digesù C; D'Onofrio I; Rosato H; Valentini V
    Rays; 2005; 30(2):181-7. PubMed ID: 16294912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
    Schwarz M; Lebesque JV; Mijnheer BJ; Damen EM
    Radiother Oncol; 2004 Nov; 73(2):209-18. PubMed ID: 15542168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancer.
    García-Vicente F; Zapatero A; Floriano A; Cruz-Conde A; Perez L; Marín A; Mínguez C; Torres JJ
    Med Phys; 2005 Aug; 32(8):2503-9. PubMed ID: 16193780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial.
    Koper PC; Jansen P; van Putten W; van Os M; Wijnmaalen AJ; Lebesque JV; Levendag PC
    Radiother Oncol; 2004 Oct; 73(1):1-9. PubMed ID: 15465140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the variation in rectal dose due to inter-fraction rectal wall deformation in external beam prostate treatments.
    Booth J; Zavgorodni S
    Phys Med Biol; 2005 Nov; 50(21):5055-74. PubMed ID: 16237241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.
    Cheung R; Tucker SL; Ye JS; Dong L; Liu H; Huang E; Mohan R; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1513-9. PubMed ID: 15050331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.